宏達高科(002144.SZ):2020年度擬向銀行申請總額度不超4.8億元綜合授信額度
格隆匯4月21日丨宏達高科(002144.SZ)公佈,根據公司做大做強醫療器械產業、做強做精經編面料產業的戰略要求,為保證公司現金流量充足,滿足生產經營融資需求,公司(含控股子公司、孫公司)2020年度擬向銀行申請總額度不超過人民幣4.80億元(最終以銀行實際審批的授信額度為準)的綜合授信額度。公司董事會授權董事長沈國甫簽署與以上授信業務有關的法律文件;控股子公司、孫公司的法律文件的簽署人按其章程規定確定,在其章程無明確規定的情況下,由宏達高科法定代表人授權或指定的代表簽署。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.